If you want to find the best deals and sale items, it’s wise to head directly to the back of the store and work your way up to the front. [More]
If your teenager is quick to anger and depression, disagreeable and likes to break rules, video games may not just be letting him blow off steam, but may actually accentuate his dark tendencies, a study by professors from Villanova and Rutgers concluded. [More]
Networks and advertisers alike are understandably worried that the commercial-obliterating magic of DVR would render ad spots irrelevant. The fears are unfounded, according to Duke University business professor Carl Mela, whose study found that the Aflac duck and Verizon Can You Hear Me Now Guy won’t go down so easily. [More]
A judge just invalidated the patents on two human genes whose mutations have been linked to breast and ovarian cancer. The genes were isolated by a biotech firm called Myriad Genetics, which argued that because it figured out how to isolate the genes outside of the human body then they were patentable. The judge called that “a ‘lawyer’s trick’ that circumvents the prohibition on the direct patenting of the DNA in our bodies.” The company sells a $3,000 cancer screening kit and has maintained a monopoly on the test because of the patents. [More]
Are you tired of forgetting whether you should add creatine or cinnamon to your kale smoothie? Do you worry that the milk thistle you’ve rubbed on your genitals isn’t helping? The “Snake Oil?” graphic at informationisbeautiful.net can help you out–it provides a graphical overview of 166 different health supplements and arranges them according to how much evidence there is that they actually work. [More]
All the money that Amazon has sunk into infrastructure and rapid fulfillment has paid off–the online retail giant was the most trusted brand of 2009, according to a brand study released by Millward Brown. The market research company spent 2009 asking consumers questions like, “How trustworthy is this brand?” and, “Would you recommend this brand?” [More]
You know what’s great about subscriptions? You forget to cancel them. You also pay more over time than you would if you were forced to buy items individually. Yeah, that’s awesome—for companies. The New York Times looks at current research on how consumers think about subscriptions, and why companies want to push them more than ever.
Here’s an interesting discovery about mortgage defaults from the LA Times:
After our post yesterday ended up crashing the National Association of Insurance Commissioners’ consumer information website, we received an email from them. They said they wanted to explain how the site works to address some reader questions, as well as point out that you too can contribute to the rankings by filing complaints when your insurer does something objectionable.
So you suspect your health/auto/home insurer is run by the devil, but you’re not sure whether the alternative you’re considering is any better. Kiplinger Finance has posted a helpful article on how to find the complaint ratio of an insurer via the National Association of Insurance Commissioners’ website. Update: here’s how to file your own complaint.
Engine Industries used Google Trends to map the frequency of search terms like “used car,” “new car,” and “buy car” through Google. They found that “people search car-related keyterms most in the summer and least in the winter, with a small spike right before Christmas.”
Now, you know what they say about green M&Ms. That isn’t true. But have you heard what they say about blue M&Ms? That the dye they contain can help the body to repair damage from spinal cord injuries? That one’s true. Oh, and the dye also turns rodents blue.
A PR person just contacted us on behalf of the U.S. Treasury Department to point out that there are $16 billion in unredeemed bonds that are no longer earning interest. “Specifically, there are 40 million Series E savings bonds purchased between 1941 and 1978 that are over 30 years old and therefore have fully matured. They can be cashed out today for at least four times their face value.”
The latest study of people who take large amounts of non-steroidal anti-inflammatory drugs (NSAIDs) indicates that, contrary to what earlier studies suggested, they don’t seem to cut the risk of developing Alzheimer’s. In fact, it’s just the opposite: “During the study, 476 people developed dementia, and heavy NSAID users had a 66% higher risk of developing the condition than those with low or no use.”
That topical spray we mentioned last week—the one designed to help premature ejaculators—turns out to just be a mixture of lidocaine and prilocaine. Lidocaine is commonly used by dentists to numb the mouth, and prilocaine is used to numb skin before inserting a needle. But beyond that, Consumer Reports points out that side effects reported by the men and their partners in the study included a “rash on their penis” or “a burning sensation in their vagina.”